Carella AM - Search Results

1

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.

Mauro FR, Molica S, Laurenti L, Cortelezzi A, Carella AM, Zaja F, Chiarenza A, Angrilli F, Nobile F, Marasca R, Musolino C, Brugiatelli M, Piciocchi A, Vignetti M, Fazi P, Gentile G, De Propris MS, Della Starza I, Marinelli M, Chiaretti S, Del Giudice I, Nanni M, Albano F, Cuneo A, Guarini A, Foà R; Gruppo Italiano Malattie EMatologiche dell’Adulto Working Party for Chronic Lymphoproliferative Disorders. Mauro FR, et al. Among authors: carella am. Leuk Res. 2014 Feb;38(2):198-203. doi: 10.1016/j.leukres.2013.11.009. Epub 2013 Nov 19. Leuk Res. 2014. PMID: 24314589 Clinical Trial.

2

Intensive conventional chemotherapy can lead to a precocious overshoot of cytogenetically normal blood stem cells (BSC) in chronic myeloid leukemia and acute lymphoblastic leukemia.

Carella AM, Pollicardo N, Raffo MR, Podesta M, Carlier P, Valbonesi M, Lercari G, Vitale V, Gallamini A. Carella AM, et al. Leukemia. 1992 Nov;6 Suppl 4:120-3. Leukemia. 1992. PMID: 1359202

3

Autologous bone marrow transplantation for acute myeloid and lymphoid leukemia.

Rizzoli V, Carlo-Stella C, Almici C, Garau D, Carella AM, Coser P, Angrilli F, Bernabei PA, Mozzana R, Alessandrino E, et al. Rizzoli V, et al. Among authors: carella am. Leukemia. 1992 Nov;6 Suppl 4:103-5. Leukemia. 1992. PMID: 1434811 Clinical Trial. No abstract available.

4

Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A.

Carella AM, Gaozza E, Raffo MR, Carlier P, Frassoni F, Valbonesi M, Lercari G, Sessarego M, Defferrari R, Guerrasio A, et al. Carella AM, et al. Leukemia. 1991 Jun;5(6):517-21. Leukemia. 1991. PMID: 1676080

5

Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).

Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett A, Rizzoli V, Alessandrino EP, Bjorkstrand B, et al. Gorin NC, et al. Leukemia. 1991 Oct;5(10):896-904. Leukemia. 1991. PMID: 1835746

6

Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group.

Carella AM, Carlier P, Pungolino E, Resegotti L, Liso V, Stasi R, Montillo M, Iacopino P, Mirto S, Pagano L, et al. Carella AM, et al. Leukemia. 1993 Feb;7(2):196-9. Leukemia. 1993. PMID: 8426473

7

Collection, analysis and transplantation of Ph-negative blood precursor cells in chronic myeloid leukemia.

Frassoni F, Carella AM. Frassoni F, et al. Among authors: carella am. Leukemia. 1996 Jun;10 Suppl 2:s30-2. Leukemia. 1996. PMID: 8649050

8

High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial.

Federico M, Clò V, Carella AM. Federico M, et al. Among authors: carella am. Leukemia. 1996 Jun;10 Suppl 2:s69-71. Leukemia. 1996. PMID: 8649056 Clinical Trial.

9

Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.

Carella AM, Prencipe E, Pungolino E, Lerma E, Frassoni F, Rossi E, Giordano D, Occhini D, Gatti AM, Bruni R, Spriano M, Nati S, Pierluigi D, Congiu M, Vimercati R, Ravetti JL, Federico M. Carella AM, et al. Leuk Lymphoma. 1996 Mar;21(1-2):63-70. doi: 10.3109/10428199609067581. Leuk Lymphoma. 1996. PMID: 8907271 Clinical Trial.

10

Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study.

Carella AM, Cascavilla N, Greco MM, Melillo L, Sajeva MR, Ladogana S, D'Arena G, Perla G, Carotenuto M. Carella AM, et al. Leuk Lymphoma. 2001 Jan;40(3-4):295-303. doi: 10.3109/10428190109057928. Leuk Lymphoma. 2001. PMID: 11426551 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters